Roivant to Report Financial Results for the First Quarter Ended June 30, 2025, and Provide Business Update on Monday, August 11, 2025

Company Overview - Roivant is a biopharmaceutical company focused on improving patient lives by accelerating the development and commercialization of important medicines [3] - The company's pipeline includes several product candidates such as IMVT-1402, batoclimab, brepocitinib, and mosliciguat, targeting various autoimmune and pulmonary conditions [3] Upcoming Events - Roivant will host a live conference call and webcast on August 11, 2025, at 8:00 a.m. ET to report its financial results for the first quarter ended June 30, 2025, and provide a business update [1] Access Information - Interested parties can access the conference call by registering online, with details available on Roivant's investor website [2]